Skip to menu Skip to content Skip to footer
Dr Christine Staatz
Dr

Christine Staatz

Email: 
Phone: 
+61 7 334 61974

Overview

Background

Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.

She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.

In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).

On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.

Research Interests

Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.

Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.

Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.

Christine’s current projects include:

  • Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
  • Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
  • Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
  • Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
  • Improving gentamycin dosing in paediatric oncology patients
  • Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
  • Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
  • Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis

Projects currently available for interested research higher degree students include:

  • Dose optimisation of busulfan in paediatric bone marrow transplant recipients
  • Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
  • Examining Bayesian forecasting methods to predict immunosuppressant exposure
  • Examining the international use of immunosuppressant and anti-rheumatic drugs
  • Examining the influence of plasma exchange on immunosuppressant drug exposure

Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.

Teaching interests

Co-ordinates:

  • PHRM3052- Biological Fate of Drugs

Teaches in:

  • PHRM3052- Biological Fate of Drugs
  • PHRM3011- Quality Use of Medicines

Availability

Dr Christine Staatz is:
Available for supervision

Qualifications

  • Bachelor, The University of Queensland
  • Bachelor (Honours) of Pharmacy, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Christine Staatz’s works on UQ eSpace

249 works between 1998 and 2025

1 - 20 of 249 works

2025

Journal Article

Examining whole blood, total and free plasma tacrolimus in elderly kidney transplant recipients

Cossart, Amelia R., Isbel, Nicole M., Campbell, Scott B., McWhinney, Brett and Staatz, Christine E. (2025). Examining whole blood, total and free plasma tacrolimus in elderly kidney transplant recipients. Therapeutic Drug Monitoring, 47 (1), 161-168. doi: 10.1097/ftd.0000000000001274

Examining whole blood, total and free plasma tacrolimus in elderly kidney transplant recipients

2024

Journal Article

Does Age Influence Immunosuppressant Drug Pharmacokinetics in Kidney Transplant Recipients?

Cossart, Amelia R., Isbel, Nicole M., Campbell, Scott B., McWhinney, Brett and Staatz, Christine E. (2024). Does Age Influence Immunosuppressant Drug Pharmacokinetics in Kidney Transplant Recipients?. European Journal of Drug Metabolism and Pharmacokinetics, 49 (6), 751-761. doi: 10.1007/s13318-024-00914-3

Does Age Influence Immunosuppressant Drug Pharmacokinetics in Kidney Transplant Recipients?

2024

Journal Article

Preparedness of pharmacy students and preceptors for work integrated learning in an undergraduate Pharmacy program

Quach, Thien An, Staatz, Christine, Lee, Jane, Fejzic, Jasmina and Hardman, Caitlin (2024). Preparedness of pharmacy students and preceptors for work integrated learning in an undergraduate Pharmacy program. The Australian Pharmacy Students' Journal, 3 (2), 15-29. doi: 10.55136/apsj326

Preparedness of pharmacy students and preceptors for work integrated learning in an undergraduate Pharmacy program

2024

Journal Article

Metformin for preventing the progression of chronic kidney disease

El-Damanawi, Ragada, Stanley, Isabelle Kitty, Staatz, Christine, Pascoe, Elaine M., Craig, Jonathan C., Johnson, David W., Mallett, Andrew J., Hawley, Carmel M., Milanzi, Elasma, Hiemstra, Thomas F. and Viecelli, Andrea K. (2024). Metformin for preventing the progression of chronic kidney disease. Cochrane Database of Systematic Reviews, 2024 (6) CD013414. doi: 10.1002/14651858.cd013414.pub2

Metformin for preventing the progression of chronic kidney disease

2024

Journal Article

Efficacy and safety of fibroblast growth factor‐21 analogs for the treatment of metabolic dysfunction‐associated steatohepatitis: a systematic review and meta‐analysis

Jeong, Changhyeon, Han, Nayoung, Jeon, Nakyung, Rhee, Su‐jin, Staatz, Christine E., Kim, Min‐Soo and Baek, In‐hwan (2024). Efficacy and safety of fibroblast growth factor‐21 analogs for the treatment of metabolic dysfunction‐associated steatohepatitis: a systematic review and meta‐analysis. Clinical Pharmacology and Therapeutics, 116 (1), 72-81. doi: 10.1002/cpt.3278

Efficacy and safety of fibroblast growth factor‐21 analogs for the treatment of metabolic dysfunction‐associated steatohepatitis: a systematic review and meta‐analysis

2024

Journal Article

A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials

Stanley, I. Kitty, Palma, Anton M., Viecelli, Andrea K., Johnson, David W., Hawley, Carmel M., Staatz, Christine E. and Mallett, Andrew J. (2024). A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials. Journal of Nephrology, 37 (5), 1417-1419. doi: 10.1007/s40620-024-01906-x

A secondary analysis of concurrent use of metformin and tolvaptan in ADPKD tolvaptan trials

2024

Journal Article

A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline

Stanley, Kitty, Mallett, Andrew J., Viecelli, Andrea K., Hawley, Carmel M., Staatz, Christine E., Johnson, David W. and Milanzi, Elasma (2024). A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline. Kidney International Reports, 9 (5), 1525-1527. doi: 10.1016/j.ekir.2024.02.011

A post hoc analysis of the CKD-FIX study analysing the association between metformin usage and eGFR decline

2024

Journal Article

Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis

Na, Hyun-jin, Jeon, Nakyung, Staatz, Christine E, Han, Nayoung and Baek, In-hwan (2024). Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis. SLEEP, 47 (2) zsad293, 1-11. doi: 10.1093/sleep/zsad293

Clinical safety and narcolepsy-like symptoms of dual orexin receptor antagonists in patients with insomnia: a systematic review and meta-analysis

2024

Journal Article

The association between tacrolimus exposure and tremor, headache and insomnia in adult kidney transplant recipients: a systematic review

King, Catherine P., Cossart, Amelia R., Isbel, Nicole M., Campbell, Scott B. and Staatz, Christine E. (2024). The association between tacrolimus exposure and tremor, headache and insomnia in adult kidney transplant recipients: a systematic review. Transplantation Reviews, 38 (1) 100815, 1-12. doi: 10.1016/j.trre.2023.100815

The association between tacrolimus exposure and tremor, headache and insomnia in adult kidney transplant recipients: a systematic review

2024

Conference Publication

Prediction of intracellular tacrolimus concentrations in stabile kidney transplanted adults using a population pharmacokinetic modelling approach.

Katrine Agergaard, K., Thiesson, H.C., Carstens, J., Staatz, C.E., Järvinen, E., Nielsen, F., Christensen, H.D., Juhl-Sandberg, R., Brøsen, K., Stage, T.B., Andersen, D.T., Kjellsson, M.C. and Bergmann, T.K. (2024). Prediction of intracellular tacrolimus concentrations in stabile kidney transplanted adults using a population pharmacokinetic modelling approach.. Scandinavian Transplantation Society, Aarhus, Denmark, 29-31 May 2024.

Prediction of intracellular tacrolimus concentrations in stabile kidney transplanted adults using a population pharmacokinetic modelling approach.

2024

Conference Publication

Population pharmacokinetic modelling of whole blood and intracellular tacrolimus in adult kidney transplanted patients.

Katrine Agergaard, K., Thiesson, H.C., Carstens, J., Staatz, C.E., Järvinen, E., Nielsen, F., Christensen, H.D., Juhl-Sandberg, R., Brøsen, K., Stage, T.B., Andersen, D.T., Kjellsson, M.C. and Bergmann, T.K. (2024). Population pharmacokinetic modelling of whole blood and intracellular tacrolimus in adult kidney transplanted patients.. Population Approach Group in Europe, Rome, Italy, 25-28 June 2024.

Population pharmacokinetic modelling of whole blood and intracellular tacrolimus in adult kidney transplanted patients.

2024

Conference Publication

Comparison of methods to estimate busulfan exposure in paediatric bone marrow transplantation.

Siddique, N., Staatz, C.E. and Lawson, R. (2024). Comparison of methods to estimate busulfan exposure in paediatric bone marrow transplantation.. ASCEPT, APFP & APSA Congress, Melbourne, VIC, Australia, 1-4 December 2024.

Comparison of methods to estimate busulfan exposure in paediatric bone marrow transplantation.

2024

Conference Publication

Population pharmacokinetic modelling of intracellular tacrolimus in stable kidney transplanted patients.

Agergaard, K., Thiesson, H.C., Carstens, J., Kjellsson, M., Staatz, C.E., Järvinen, E., Nielsen, F., Christensen, H.D., Juhl-Sandberg, R., Brøsen, K., Stage, T.B. and Bergmann, T.K. (2024). Population pharmacokinetic modelling of intracellular tacrolimus in stable kidney transplanted patients.. Danish Society of Pharmacology., Odense, Denmark, 16 January 2024.

Population pharmacokinetic modelling of intracellular tacrolimus in stable kidney transplanted patients.

2024

Conference Publication

Metformin for preventing the progression of chronic kidney disease: a Cochrane systematic review

Ragada El-Damanawi, R., Stanley, I.K., Staatz, C., Pascoe, E.M., Craig, J.C., Johnson, D.W., Hawley, C.M., Mallett, A.J., Milanzi, E., Hiemstra, T.F. and Viecelli, A.K. (2024). Metformin for preventing the progression of chronic kidney disease: a Cochrane systematic review. Australian and New Zealand Society of Nephrology Annual Scientific meeting., Adelaide, SA, Australia, 31 August – 4 September 2024. HOBOKEN: WILEY.

Metformin for preventing the progression of chronic kidney disease: a Cochrane systematic review

2024

Journal Article

Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients

Agergaard, Katrine, Thiesson, Helle C., Carstens, Jan, Staatz, Christine E., Järvinen, Erkka, Nielsen, Flemming, Christensen, Heidi Dahl, Juhl-Sandberg, Rikke, Brøsen, Kim, Stage, Tore Bjerregaard, Andersen, Dorte Terp, Kjellsson, Maria C. and Bergmann, Troels K. (2024). Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients. British Journal of Clinical Pharmacology. doi: 10.1111/bcp.16277

Population pharmacokinetics of tacrolimus whole blood and peripheral blood mononuclear cell concentrations in stable kidney-transplanted patients

2023

Journal Article

Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: a systematic review and meta-analysis

Jang, Hyejung, Han, Nayoung, Staatz, Christine E., Kwak, Jae-Hwan and Baek, In-hwan (2023). Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: a systematic review and meta-analysis. Clinics and Research in Hepatology and Gastroenterology, 47 (10) 102227, 102227. doi: 10.1016/j.clinre.2023.102227

Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: a systematic review and meta-analysis

2023

Conference Publication

Limited sampling strategies to estimate tacrolimus whole blood, total plasma, and free plasma exposure.

Masoud, D., Cossart, A.R., Isbel, N.M., Campbell, S.B., McWhinney, B. and Staatz, C.E. (2023). Limited sampling strategies to estimate tacrolimus whole blood, total plasma, and free plasma exposure.. International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Oslo, Norway, 24-27 September 2023.

Limited sampling strategies to estimate tacrolimus whole blood, total plasma, and free plasma exposure.

2023

Conference Publication

Trimethoprim-sulfamethoxazole pharmacokinetic evaluation in adult kidney transplant recipients.

Scuderi, C.E., Parker, S.L., Jacks, M., John, G.T., McWhinney, B., Ungerer, J., Mallett, A.J., Healy, H.G., Roberts, J.A. and Staatz, C.E. (2023). Trimethoprim-sulfamethoxazole pharmacokinetic evaluation in adult kidney transplant recipients.. World Congress on Pharmacy and Pharmaceutical Sciences., Brisbane, QLD Australia, 24-28 September 2023.

Trimethoprim-sulfamethoxazole pharmacokinetic evaluation in adult kidney transplant recipients.

2023

Conference Publication

Management of neonatal seizures by neonatologists and paediatric neurologists: A survey of practice in Australia and New Zealand.

Williams, A., Liley, H. and Staatz, C.E. (2023). Management of neonatal seizures by neonatologists and paediatric neurologists: A survey of practice in Australia and New Zealand.. European Society for Developmental, Perinatal and Paediatric Pharmacology, Prague, Czech Republic, 28-30 June 2023.

Management of neonatal seizures by neonatologists and paediatric neurologists: A survey of practice in Australia and New Zealand.

2023

Journal Article

Serum creatinine and tacrolimus assessment with VAMS finger-prick microsampling: a diagnostic test study

Scuderi, Carla E., Parker, Suzanne L., Jacks, Margaret, John, George T., McWhinney, Brett, Ungerer, Jacobus, Mallett, Andrew J., Healy, Helen G., Roberts, Jason A. and Staatz, Christine E. (2023). Serum creatinine and tacrolimus assessment with VAMS finger-prick microsampling: a diagnostic test study. Kidney Medicine, 5 (4) 100610, 100610. doi: 10.1016/j.xkme.2023.100610

Serum creatinine and tacrolimus assessment with VAMS finger-prick microsampling: a diagnostic test study

Funding

Current funding

  • 2024 - 2026
    Exploring the impact of BUsulfan METabolites on busulfan clearance, exposure and patient outcomes following Haematopoietic Stem Cell Transplantation (BU-MET-HSCT). (QHCRF administered by CHQ HHS)
    Children's Health Queensland Hospital and Health Service
    Open grant

Past funding

  • 2019 - 2020
    Evaluating immunosuppressant medicines in elderly renal transplant recipients
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2019
    Bu4DayPK - Analysis of once daily IV Busulfan in paediatric HSCT patients
    Children's Health Queensland Hospital and Health Service
    Open grant
  • 2018 - 2019
    Innovative blood sampling to reduce the burden of long-term treatment for kidney transplant recipients
    Metro North Hospital and Health Service
    Open grant
  • 2014
    Designing optimal dosing regimens for immunosuppressant medications
    Queensland Pharmacy Research Trust
    Open grant
  • 2010 - 2011
    Examining the relationship between immunosuppression and BK virus infection in adult kidney transplant recipients
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2010
    Analytical instrumentation enabling rapid compound separation and chemical structure analysis via mass fingerprinting
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008 - 2011
    Lions Medical Research Foundation Fellowship - Tailoring doses of the newer immunosuppressant drugs to improve outcomes after transplant
    Lions Medical Research Foundation
    Open grant
  • 2008 - 2011
    Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs
    NHMRC Project Grant
    Open grant
  • 2008
    UQ Travel Awards Category 2 - Christine Staatz
    UQ Travel Grants Scheme
    Open grant
  • 2004 - 2008
    NEIL HAMILTON FAIRLEY FELLOWSHIP: Population Pharmacokinetic And Pharmacodynamic Modelling Of The Newer Immunosuppressant Drugs
    NHMRC Training (Postdoctoral) Fellowship
    Open grant

Supervision

Availability

Dr Christine Staatz is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Dr Christine Staatz's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au